Targeting PIM kinase activity significantly augments the efficacy of cytarabine

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)129-132
Number of pages4
JournalBritish Journal of Haematology
Volume156
Issue number1
DOIs
StatePublished - Jan 2012
Externally publishedYes

Keywords

  • AML
  • Drug resistance
  • Leukaemia therapy
  • New drug development
  • New drugs for leukaemia

ASJC Scopus subject areas

  • Hematology

Cite this